BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 150,728 Value ($000) $1,152 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 129,317 Value ($000) $982 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 106,483 Value ($000) $954 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 116,258 Value ($000) $872 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 84,662 Value ($000) $508 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 29,127 Value ($000) $221 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 27,913 Value ($000) $173 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 32,257 Value ($000) $164 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 23,439 Value ($000) $140 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 13,413 Value ($000) $86 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 52,082 Value ($000) $367 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 58,880 Value ($000) $491 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 21,360 Value ($000) $245 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 52,587 Value ($000) $663 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 23,656 Value ($000) $250 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 17,806 Value ($000) $290 Avg Close $16.04 Range $11.56 - $19.99
Q3 2021
Shares 10,423 Value ($000) $150 Avg Close $15.77 Range $14.00 - $18.48